Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 2
1948 7
1949 4
1950 4
1951 2
1952 4
1953 3
1954 3
1955 2
1956 7
1957 2
1958 2
1959 2
1960 4
1961 6
1962 7
1963 4
1964 6
1965 7
1966 18
1967 35
1968 44
1969 49
1970 60
1971 69
1972 88
1973 111
1974 148
1975 429
1976 585
1977 514
1978 570
1979 660
1980 719
1981 676
1982 821
1983 845
1984 958
1985 1149
1986 1352
1987 1475
1988 1544
1989 1790
1990 2173
1991 2128
1992 2075
1993 2257
1994 2503
1995 2496
1996 2507
1997 2502
1998 2625
1999 2695
2000 2776
2001 3101
2002 3566
2003 4179
2004 4255
2005 4426
2006 4540
2007 4687
2008 4591
2009 4579
2010 4669
2011 4611
2012 4435
2013 4366
2014 4321
2015 4435
2016 4179
2017 4086
2018 3771
2019 3576
2020 2805
2021 1772
2022 392
2023 272
2024 1718
2025 682

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

119,786 results

Results by year

Filters applied: . Clear all
Page 1
Xenotransplantation 2.0.
[No authors listed] [No authors listed] Nat Biotechnol. 2016 Jan;34(1):1. doi: 10.1038/nbt.3466. Nat Biotechnol. 2016. PMID: 26744955 No abstract available.
Combined chemotherapy.
Goldin A. Goldin A. Oncology. 1980;37 Suppl 1:3-8. doi: 10.1159/000225489. Oncology. 1980. PMID: 7005787 Review.
(d) Treatment of metastatic and sequestered tumor cells. (e) Identification of optimal dosages, ratios and schedules for drug combinations. (f) Kinetic considerations such as tumor cell synchronization, choice of drugs that act at different phases of the cell cycle …
(d) Treatment of metastatic and sequestered tumor cells. (e) Identification of optimal dosages, ratios and schedules for drug …
Chemoradiation schedules--what radiotherapy?
Glynne-Jones R, Sebag-Montefiore D. Glynne-Jones R, et al. Eur J Cancer. 2002 Jan;38(2):258-69. doi: 10.1016/s0959-8049(01)00370-7. Eur J Cancer. 2002. PMID: 11803142 Review.
Synchronous chemoradiation (SCRT) is playing an increasing role in the primary and multimodality management of cancer in many disease sites. Current schedules have been in the main empirically derived, and the addition of chemotherapy has in some cases led to a compromise …
Synchronous chemoradiation (SCRT) is playing an increasing role in the primary and multimodality management of cancer in many disease sites. …
Ototoxicity due to cis-diamminedichloroplatinum in the treatment of ovarian cancer: influence of dosage and schedule of administration.
Waters GS, Ahmad M, Katsarkas A, Stanimir G, McKay J. Waters GS, et al. Ear Hear. 1991 Apr;12(2):91-102. doi: 10.1097/00003446-199104000-00003. Ear Hear. 1991. PMID: 2065844 Clinical Trial.
The purpose was to determine the influence of dosage, schedule of administration, and long-term treatment on pure-tone thresholds and other auditory parameters. ...The treatment protocol consisted of two different dosages (low--50 mg/m2 and high--100 mg/m2) a …
The purpose was to determine the influence of dosage, schedule of administration, and long-term treatment on pure-tone thresho …
1956 Emergency dosage schedule.
VAN RIPER HE. VAN RIPER HE. J Am Med Womens Assoc. 1956 Jul;11(7):255-6. J Am Med Womens Assoc. 1956. PMID: 13345647 No abstract available.
Evolution of carfilzomib dose and schedule in patients with multiple myeloma: a historical overview.
Jakubowiak AJ. Jakubowiak AJ. Cancer Treat Rev. 2014 Jul;40(6):781-90. doi: 10.1016/j.ctrv.2014.02.005. Epub 2014 Mar 1. Cancer Treat Rev. 2014. PMID: 24630735 Free article. Review.
Based on in vitro and in vivo findings and encouraging phase I tolerability data, a consecutive-day, twice-weekly dosing schedule was implemented early in the development program. Other phase II studies have led to further refinements in the dosing schedule of carfi …
Based on in vitro and in vivo findings and encouraging phase I tolerability data, a consecutive-day, twice-weekly dosing schedule was …
Extended-schedule oral etoposide in selected neoplasms and overview of administration and scheduling issues.
Hainsworth JD. Hainsworth JD. Drugs. 1999;58 Suppl 3:51-6. doi: 10.2165/00003495-199958003-00008. Drugs. 1999. PMID: 10711842 Review.
Extended schedules of oral etoposide have been evaluated in many types of advanced cancer. In addition to their use in the common solid tumours, extended schedules have been employed in Kaposi's sarcoma (both AIDS-related and endemic types), medulloblastoma, glioma, …
Extended schedules of oral etoposide have been evaluated in many types of advanced cancer. In addition to their use in the common sol …
Behavioural nudges increase COVID-19 vaccinations.
Dai H, Saccardo S, Han MA, Roh L, Raja N, Vangala S, Modi H, Pandya S, Sloyan M, Croymans DM. Dai H, et al. Nature. 2021 Sep;597(7876):404-409. doi: 10.1038/s41586-021-03843-2. Epub 2021 Aug 2. Nature. 2021. PMID: 34340242 Free PMC article. Clinical Trial.
Implications of overall time in radiotherapy.
Dale RG, Jones B. Dale RG, et al. Clin Oncol (R Coll Radiol). 1993;5(6):339-40. doi: 10.1016/s0936-6555(05)80081-0. Clin Oncol (R Coll Radiol). 1993. PMID: 8305350 No abstract available.
Scheduling of taxanes: a review.
Woodward EJ, Twelves C. Woodward EJ, et al. Curr Clin Pharmacol. 2010 Aug;5(3):226-31. doi: 10.2174/157488410791498725. Curr Clin Pharmacol. 2010. PMID: 20406166 Review.
The taxanes are widely used in the cytotoxic treatment of many solid tumours. Their optimal scheduling, however, remains unconfirmed. Here we review the development of both paclitaxel and docetaxel to identify evidence influencing the choice of schedule. ...Paclitax …
The taxanes are widely used in the cytotoxic treatment of many solid tumours. Their optimal scheduling, however, remains unconfirmed. …
119,786 results
You have reached the last available page of results. Please see the User Guide for more information.